Acad Radiol
- CAO Y, Zhu H, Li Z, Liu C, et al
CT Image-Based Radiomic Analysis for Detecting PD-L1 Expression Status in Bladder
Cancer Patients.
Acad Radiol. 2024 Mar 30:S1076-6332(24)00138-7. doi: 10.1016/j.acra.2024.
Acta Cytol
- TANAKA S, Tokuhara Y, Ariyasu S, Morinishi T, et al
Diagnostic Immunocytostaining with Peroxisome Proliferator-Activated
Receptor-Gamma in Urine Cytology Samples.
Acta Cytol. 2024;68:60-65.
Acta Pharm
- JAIN NK, Tailang M, Thangavel N, Makeen HA, et al
A comprehensive overview of selective and novel fibroblast growth factor receptor
inhibitors as a potential anticancer modality.
Acta Pharm. 2024;74:1-36.
Actas Urol Esp (Engl Ed)
- TORIBIO-VAZQUEZ C, Gomez Rivas J, Amigo F, Carrion DM, et al
Prevalence of urinary tract cancer in the Spanish cohort of the IDENTIFY study.
Actas Urol Esp (Engl Ed). 2024;48:228-237.
- MONTOSA RODENAS P, Gomez Huertas M, Perez Rosillo MA, Lainez Ramos-Bossini AJ, et al
Intravesical fat-fluid level as a warning sign of contained bladder perforation:
Correlation between cystoscopy and computed tomography findings.
Actas Urol Esp (Engl Ed). 2024;48:254-256.
- LOPEZ VALCARCEL M, Barrado Los Arcos M, Ferri Molina M, Cienfuegos Belmonte I, et al
Is trimodal therapy the current standard for muscle-invasive bladder cancer?
Actas Urol Esp (Engl Ed). 2024 Apr 2:S2173-5786(24)00028.
Adv Healthc Mater
- HOHAGEN M, Sanchez L, Herbst AJ, Kahlig H, et al
MANNosylation of Mesoporous Silica Nanoparticles Modifies TLR4 Localization and
NF-kappaB Translocation in T24 Bladder Cancer Cells.
Adv Healthc Mater. 2024 Mar 30:e2304150. doi: 10.1002/adhm.202304150.
Ann Surg Oncol
- OMURA M, Kosaka T, Kobayashi H, Shigeta K, et al
ASO Author Reflections: Vasohibin-1 as a Biomarker for Chemotherapeutic Response
in Patients with Advanced Bladder Cancer.
Ann Surg Oncol. 2024 Apr 2. doi: 10.1245/s10434-024-15122.
- SLUSARCZYK A, Ismail H, Zapala L, Piecha T, et al
Changes in the Urinary Microbiome After Transurethral Resection of
Non-muscle-Invasive Bladder Cancer: Insights from a Prospective Observational
Study.
Ann Surg Oncol. 2024 Apr 3. doi: 10.1245/s10434-024-15198.
Asia Pac J Clin Oncol
- COLAK R, Erdem GU, Kapar C, Gulturk I, et al
Change in the neutrophil-lymphocyte ratio may predict early recurrence in
operated bladder cancer.
Asia Pac J Clin Oncol. 2024 Apr 4. doi: 10.1111/ajco.14065.
Asian J Endosc Surg
- KADORIKU F, Sasaki Y, Fukuta K, Nishiyama M, et al
Robot-assisted intracorporeal ileal conduit urinary diversion: A two-center
comparative study of Bricker versus Wallace ureteroileal anastomosis.
Asian J Endosc Surg. 2024;17:e13307.
Asian J Surg
- CHEN BH, Hsieh SJ, Chiu B
Non-functional bladder paraganglioma with urinary frequency: A case report.
Asian J Surg. 2024;47:1990-1991.
- ZHANG KY, Hu JS, Liu XH
Efficacy and safety of robot-assisted total cystectomy: A systematic review and
meta-analysis.
Asian J Surg. 2024;47:2028-2032.
- FENG X, Chen Z
Case report and literature review of penile metastasis of bladder cancer.
Asian J Surg. 2024 Mar 29:S1015-9584(24)00529.
- XIN JH, Jiang B, Yuan YH, Zou XF, et al
Primary diffuse large B-cell lymphoma of the urinary bladder: A case report.
Asian J Surg. 2024;47:1930-1931.
- HUANG P, Xin JH, Zou XF, Wu GQ, et al
Isolated myeloid sarcoma in the urinary bladder: A cases report.
Asian J Surg. 2024;47:1928-1929.
- SU BY, Tan H, Bao JS, He QQ, et al
Obstructive ureteral calculi and upper-tract urothelial carcinoma: A tale of two
cases.
Asian J Surg. 2024;47:1825-1826.
Biochem Pharmacol
- DING X, Jin Y, Shi X, Wang Y, et al
TDO2 promotes bladder cancer progression via AhR-mediated SPARC/FILIP1L
signaling.
Biochem Pharmacol. 2024 Mar 27:116172. doi: 10.1016/j.bcp.2024.116172.
BMJ Open
- LABIDI S, Meti N, Barua R, Li M, et al
Clinical variables associated with immune checkpoint inhibitor outcomes in
patients with metastatic urothelial carcinoma: a multicentre retrospective cohort
study.
BMJ Open. 2024;14:e081480.
Cancer Cell Int
- CAI T, Feng T, Li G, Wang J, et al
Deciphering the prognostic features of bladder cancer through gemcitabine
resistance and immune-related gene analysis and identifying potential small
molecular drug PIK-75.
Cancer Cell Int. 2024;24:125.
Cancer Epidemiol Biomarkers Prev
- ROSSER CJ
Assessing the Causal Relationship between Waterpipe Smoking and Bladder Cancer.
Cancer Epidemiol Biomarkers Prev. 2024;33:461-462.
Cancer Med
- WASHINGTON SL 3RD, Lonergan PE, Odisho AY, Meng MV, et al
Association of household net worth with healthcare costs after radical cystectomy
using real-world data.
Cancer Med. 2024;13:e7116.
- AHMADI S, Ambite I, Brisuda A, Hacek J, et al
Similar immune responses to alpha1-oleate and Bacillus Calmette-Guerin treatment
in patients with bladder cancer.
Cancer Med. 2024;13:e7091.
- MEAGHER M, Krause H, Elliott A, Farrell A, et al
Characterization and impact of non-canonical WNT signaling on outcomes of
urothelial carcinoma.
Cancer Med. 2024;13:e7148.
Cell Mol Biol Lett
- LIN M, Xu X, Zhou X, Feng H, et al
Sialylation on vesicular integrin beta1 determined endocytic entry of small
extracellular vesicles into recipient cells.
Cell Mol Biol Lett. 2024;29:46.
Cell Signal
- JI Q, Ma F, Zhang X, Liu Y, et al
Hsa_circ_0005320 affects cell proliferation and the cell cycle via the
IGF2BP3/CDK2 axis in bladder cancer.
Cell Signal. 2024 Mar 31:111154. doi: 10.1016/j.cellsig.2024.111154.
Clin Genitourin Cancer
- MONTGOMERY J, Lybbert D, Sana S, El-Zawahry A, et al
Urinary bother, Urinalysis, and Two-Year Efficacy Follow-Up Results of Phase I
Trial of Intravesical Bacillus Calmette-Guerin Combined with Intravenous
Pembrolizumab in Recurrent or Persistent High-Grade Non-Muscle-Invasive Bladder
Cancer after Previo
Clin Genitourin Cancer. 2024;22:102059.
Curr Opin Oncol
- NIGLIO SA, Purswani JM, Schiff PB, Lischalk JW, et al
Organ preservation in muscle-invasive urothelial bladder cancer.
Curr Opin Oncol. 2024;36:155-163.
Eur J Epidemiol
- VERMEULEN R, Bodinier B, Dagnino S, Wada R, et al
A prospective study of smoking-related white blood cell DNA methylation markers
and risk of bladder cancer.
Eur J Epidemiol. 2024 Mar 30. doi: 10.1007/s10654-024-01110.
Eur Rev Med Pharmacol Sci
- JIANG SC, Liao YG, Luo J, Hu D, et al
Comparison of intravesical chemotherapy regimens after radical nephroureterectomy
for upper tract urothelial carcinoma and analysis of risk factors for
postoperative recurrence.
Eur Rev Med Pharmacol Sci. 2024;28:2387-2395.
Eur Urol Oncol
- ACHARD V, Fournier B, D'Haese D, Krzystyniak J, et al
Radiotherapy Combined with a Radiosensitizer for Bacillus
Calmette-Guerin-unresponsive Non-muscle-invasive Carcinoma In Situ Bladder
Cancer: An Open-label, Single-arm, Multicenter, Phase 2 European Organisation for
Research and Treatment of Cancer Tri
Eur Urol Oncol. 2024 Mar 30:S2588-9311(24)00084.
Eur Urol Open Sci
- SCHROECK FR, Grubb R, MacKenzie TA, Ould Ismail AA, et al
Clinical Trial Protocol for "Replace Cysto": Replacing Invasive Cystoscopy with
Urine Testing for Non-muscle-invasive Bladder Cancer Surveillance-A Multicenter,
Randomized, Phase 2 Healthcare Delivery Trial Comparing Quality of Life During
Cancer Surv
Eur Urol Open Sci. 2024;63:19-30.
Heliyon
- HUANG Y, Lv Y, Yang B, Zhang S, et al
Enhancing m(6)A modification of lncRNA through METTL3 and RBM15 to promote
malignant progression in bladder cancer.
Heliyon. 2024;10:e28165.
Int Urol Nephrol
- BERNARDINO RM, Wettstein M, Garisto J, Fleshner NE, et al
Editorial comment to the paper: RE: low cubilin/myeloperoxidase's ratio as a
promising biomarker for prognosis of high grade T1 bladder cancer.
Int Urol Nephrol. 2024 Apr 2. doi: 10.1007/s11255-024-04035.
Int Wound J
- LUO HM, Xiong YJ
Comparing surgical site wound infection after laparoscopic and open radical
cystectomies in patients with bladder cancer.
Int Wound J. 2024;21:e14718.
J Cancer Res Clin Oncol
- LEE S, Yoon Y, Suh J, You D, et al
Association of preoperative sarcopenia with the long-term prognosis of patients
with bladder cancer undergoing radical cystectomy.
J Cancer Res Clin Oncol. 2024;150:173.
J Endourol
- SIMHAL RK, Simon DP, Wang KR, Shah YB, et al
Perioperative and Complication Related Outcomes for Robotic-Assisted vs Open
Radical Cystectomy: A Comparative National Surgical Quality Improvement Project
Analysis.
J Endourol. 2024;38:331-339.
J Exp Clin Cancer Res
- ZHOU J, Zhou R, Zhu Y, Deng S, et al
Investigating the impact of regulatory B cells and regulatory B cell-related
genes on bladder cancer progression and immunotherapeutic sensitivity.
J Exp Clin Cancer Res. 2024;43:101.
J Immunoassay Immunochem
- BEN REJEB S, Kouki N, Ben Ghachem D, Khouni H, et al
Prognostic significance of E-Cadherin and B-Catenin in non-muscle invasive
bladder cancer.
J Immunoassay Immunochem. 2024 Apr 1:1-10. doi: 10.1080/15321819.2024.2335154.
J Med Econ
- BRODTKORB TH, Knight C, Kamgar F, Teitsson S, et al
Cost-effectiveness of nivolumab versus surveillance for the adjuvant treatment of
patients with urothelial carcinoma who are at high risk of recurrence: a US payer
perspective.
J Med Econ. 2024;27:543-553.
J Natl Compr Canc Netw
- AVUDAIAPPAN AP, Prabhakar P, Eldefrawy A, Caso J, et al
CLO24-074: Impact of Neoadjuvant Chemotherapy on Survival and Pathological
Response Among Octogenarians Who Underwent Radical Cystectomy for Muscle-Invasive
Bladder Cancer.
J Natl Compr Canc Netw. 2024;22.
- AVUDAIAPPAN AP, Prabhakar P, Chundru S, Renshaw A, et al
CLO24-064: Evaluation of the Reliability of mpMRI in Diagnosing Prostate Cancer
Following Intravesical Bacillus Calmette Guerin Therapy for Bladder Cancer.
J Natl Compr Canc Netw. 2024;22.
- LIYANAGE T, Liyanage AH
QIM24-194: A Cost Effective, Noninvasive Mutiomics Assay (BCDx) for Diagnostic
Accuracy of Bladder Cancer Compares to the Gold Standard of Cytoscopy and
Cytology.
J Natl Compr Canc Netw. 2024;22.
J Robot Surg
- SASAKI Y, Izumi K, Fukuta K, Kadoriku F, et al
Impact of lymph node dissection on surgical and oncological outcomes in patients
undergoing robot-assisted radical cystectomy for bladder cancer: a multicenter
retrospective study.
J Robot Surg. 2024;18:141.
J Thromb Haemost
- CHEN Y, Jiao W, Wang Y, Liang Z, et al
MITD1 deficiency leads to poor survival via tissue factor-mediated coagulation in
bladder cancer.
J Thromb Haemost. 2024 Mar 28:S1538-7836(24)00173.
JCO Precis Oncol
- PILALA KM, Kotronopoulos G, Levis P, Giagkos GC, et al
MIR145 Core Promoter Methylation in Pretreatment Cell-Free DNA: A Liquid Biopsy
Tool for Muscle-Invasive Bladder Cancer Treatment Outcome.
JCO Precis Oncol. 2024;8:e2300414.
Mayo Clin Proc
- TEKIN B, Erickson LA, Gupta S
Secondary Involvement of the Urinary Bladder by Endometrial Carcinoma.
Mayo Clin Proc. 2024;99:680-682.
Medicine (Baltimore)
- PAN W, Liu X, Liu S
ALYREF m5C RNA methylation reader predicts bladder cancer prognosis by regulating
the tumor immune microenvironment.
Medicine (Baltimore). 2024;103:e37590.
Mol Cancer Ther
- NISHIYAMA H, Yonese J, Kawahara T, Matsumoto R, et al
TAS0313 plus Pembrolizumab for Post-Chemotherapy Immune Checkpoint
Inhibitor-Naive Locally Advanced or Metastatic Urothelial Carcinoma.
Mol Cancer Ther. 2024;23:532-540.
Mymensingh Med J
- NAHAR R, Jinnah MSA, Karim SS, Alam MM, et al
Expression of Cyclin D1 in Urothelial Carcinoma of Urinary Bladder and its
Association with Tumour Grade.
Mymensingh Med J. 2024;33:461-465.
Nat Commun
- CHENG M, Chen S, Li K, Wang G, et al
CD276-dependent efferocytosis by tumor-associated macrophages promotes immune
evasion in bladder cancer.
Nat Commun. 2024;15:2818.
Naunyn Schmiedebergs Arch Pharmacol
- ZHANG W, Wang Y, Tang Q, Li Z, et al
PAX2 mediated upregulation of ESPL1 contributes to cisplatin resistance in
bladder cancer through activating the JAK2/STAT3 pathway.
Naunyn Schmiedebergs Arch Pharmacol. 2024 Apr 4. doi: 10.1007/s00210-024-03061.
Oncol Res
- YADOLLAHVANDMIANDOAB R, Jalalizadeh M, Dionato FAV, Buosi K, et al
Clinical implications of single cell sequencing for bladder cancer.
Oncol Res. 2024;32:597-605.
PLoS One
-
Retraction: SATB1 Overexpression Regulates the Development and Progression in
Bladder Cancer through EMT.
PLoS One. 2024;19:e0301572.
Target Oncol
- LEARY JB, Enright T, Bakaloudi DR, Basnet A, et al
Frequency and Nature of Genomic Alterations in ERBB2-Altered Urothelial Bladder
Cancer.
Target Oncol. 2024 Apr 3. doi: 10.1007/s11523-024-01056.
Urol Int
- GARAZ R, Stuhler V, Stenzl A, Rottscholl R, et al
Hemangioma of the Urinary Bladder: A Brief Narrative Review of Their Diagnosis,
Histology, and Treatment Options.
Urol Int. 2024;108:83-88.
- WALACH MT, Nitschke K, Gross-Weege M, Grosshans J, et al
Cyclin A2 Expression as Predictive Biomarker in Muscle-Invasive Upper Tract
Urothelial Carcinoma.
Urol Int. 2024;108:128-136.
Urol Oncol
- STANIORSKI CJ, Yu M, Sharbaugh D, Stencel MG, et al
Predictors of persistent opioid use in bladder cancer patients undergoing radical
cystectomy: A SEER-Medicare analysis.
Urol Oncol. 2024 Apr 1:S1078-1439(24)00362-4. doi: 10.1016/j.urolonc.2024.
- PORTEN SP, Wang EY, Vohra P, Carroll PR, et al
Evaluation of URO17(R) to improve non-invasive detection of bladder cancer.
Urol Oncol. 2024 Mar 28:S1078-1439(24)00345.
- LI L, Zhang J, Zhe X, Tang M, et al
Prediction of histopathologic grades of bladder cancer with radiomics based on
MRI: Comparison with traditional MRI.
Urol Oncol. 2024 Mar 30:S1078-1439(24)00338.
Urologia
- BIZZARRI FP, Scarciglia E, Russo P, Marino F, et al
Elderly and bladder cancer: The role of radical cystectomy and orthotopic urinary
diversion.
Urologia. 2024 Mar 29:3915603241240644. doi: 10.1177/03915603241240644.
World J Urol
- SWINTON M, Devi A, Song YP, Hoskin P, et al
Beyond surgery: bladder preservation and the role of systemic treatment in
localised muscle-invasive bladder cancer.
World J Urol. 2024;42:210.
- LIN YH, Tsai HY, Wu CT
From TURP to enucleation: navigating the complex relationship between BPH
treatments and bladder cancer.
World J Urol. 2024;42:203.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016